Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests
- PMID: 36673066
- PMCID: PMC9857715
- DOI: 10.3390/diagnostics13020256
Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests
Abstract
Wilson disease and alpha1-antitrypsin deficiency are two rare genetic diseases that may impact predominantly the liver and/or the brain, and the liver and/or the lung, respectively. The early diagnosis of these diseases is important in order to initiate a specific treatment, when available, ideally before irreversible organ damage, but also to initiate family screening. This review focuses on the non-invasive diagnostic tests available for clinicians in both diseases. These tests are crucial at diagnosis to reduce the potential diagnostic delay and assess organ involvement. They also play a pivotal role during follow-up to monitor disease progression and evaluate treatment efficacy of current or emerging therapies.
Keywords: Wilson disease; alpha1-antitrypsin deficiency; diagnosis; non-invasive tests.
Conflict of interest statement
O.G. received personal fees as speaker from Echosens. M.R. received personal fees as consultant from Takeda, Grifols, and as speaker from CSL Behring.
Figures
References
-
- Schilsky M.L., Roberts E.A., Bronstein J.M., Dhawan A., Hamilton J.P., Rivard A.M., Washington M.K., Weiss K.H., Zimbrean P.C. A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: Executive Summary of the 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases. Hepatology. 2022 doi: 10.1002/hep.32805. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
